Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women

被引:8
|
作者
Fonfria-Vivas, Rosa [1 ,2 ]
Perez-Ros, Pilar [1 ,2 ]
Barrachina-Igual, Joaquin [3 ]
Pablos-Monzo, Ana [3 ]
Martinez-Arnau, Francisco M. M. [2 ,4 ]
机构
[1] Univ Valencia, Dept Nursing, Av Menendez Pelayo 19, Valencia 46010, Spain
[2] Univ Valencia, Frailty & Cognit Impairment Res Grp FROG, Menendez I Pelayo 19, Valencia 46010, Spain
[3] Univ Catolica Valencia San Vicente Martir, Fac Phys Act & Sport Sci, Ramiro de Maetzu 14, Valencia 46900, Spain
[4] Univ Valencia, Dept Physiotherapy, Gasco Oliag 5, Valencia 46010, Spain
关键词
Sarcopenia; Women; Sarcopenic obesity; Quality of life; Prevalence; SarQoL; MULTIPLE-SCLEROSIS; HEALTH; CONSENSUS; QUESTIONNAIRE; ASSOCIATION; DEFINITION; PREVALENCE; HISTORY; IMPACT; COSMIN;
D O I
10.1007/s40520-023-02488-7
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundHealth-related quality of life (HRQoL) may be impaired in the presence of sarcopenia. Since a specific quality of life questionnaire became available for sarcopenia (SarQol), cutoffs to screen for this condition have been proposed, prompting the need to assess them in different populations. Due to the lack of consensus on diagnostic criteria, the tool has not yet been analyzed in screening for sarcopenic obesity.AimOur aim is to measure the SarQoL's metric properties and establish a cutoff in QoL assessments that could be used along the diagnostic pathway for sarcopenia and sarcopenic obesity in community-dwelling older women.MethodsThis cross-sectional study assessed women aged & GE; 70 years using the SarQol, sarcopenia criteria (EWGSOP2) and sarcopenic obesity criteria (ESPEN/EASO). Cutoffs for the SarQol were defined with a receiver-operating characteristics (ROC) curve, and sensitivity and specificity were analyzed.ResultsOf the 95 included women (mean age 76.0 years, standard deviation [SD] 5.7), 7.3% (n = 7) were classified as having sarcopenic obesity, 22.1% (n = 21) as having sarcopenia, and 70.5% (n = 67) as not having sarcopenia. The total SarQol score was higher in women without sarcopenia (66.5 SD 16.2) versus those with sarcopenia (56.6 SD 15.6) and sarcopenic obesity (45.1 SD 7.9). A cutoff of & LE; 60 points is proposed for sarcopenia screening (area under the ROC curve [AUC] 0.67; 95% confidence interval [CI] 0.53-0.80; sensitivity 61.9%; specificity 62%), and & LE; 50 points for sarcopenic obesity (AUC 0.85; 95% CI 0.74-0.95; sensitivity 71.4%; specificity 76.9%).ConclusionsQuality of life is compromised in women with sarcopenia and especially in those with sarcopenic obesity. The SarQol could be useful in screening for these conditions, providing insight into health-related quality of life in older people with sarcopenia.
引用
收藏
页码:2069 / 2079
页数:11
相关论文
共 50 条
  • [31] Evaluating the Screening Capability of the SarQoL Questionnaire in Sarcopenic Obesity: A Comparison Study Between Spanish and Belgian Community-Dwelling Older Adults
    Diago-Galmes, Angela
    Guillamon-Escudero, Carlos
    Tenias-Burillo, Jose M.
    Soriano, Jose M.
    Fernandez-Garrido, Julio
    NUTRIENTS, 2024, 16 (22)
  • [32] Associations between the quality of life in sarcopenia measured with the SarQoL® and nutritional status
    Yongtaek Kim
    Ki Soo Park
    Jun Il Yoo
    Health and Quality of Life Outcomes, 19
  • [33] Translation and validation of the Taiwanese SarQoL, a quality of life questionnaire specific to sarcopenia
    Lee, Shu-Chun
    Chang, Cheng-Fen
    Wang, Jiun-Yi
    Liang, Pei-Jung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (03) : 249 - 257
  • [34] Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire
    Tsekoura, Maria
    Billis, Evdokia
    Gliatis, John
    Tsepis, Elias
    Matzaroglou, Charalampos
    Sakkas, Giorgios K.
    Beaudart, Charlotte
    Bruyere, Olivier
    Tyllianakis, Minos
    Panagiotopoulos, Elias
    DISABILITY AND REHABILITATION, 2020, 42 (07) : 1006 - 1012
  • [35] Sarcopenia and Sarcopenic Obesity in Older adults: Prevalence and Comparison of Diagnostic Criteria
    Byrne, S.
    Cummins, H.
    Thomas, P.
    Kennedy, N.
    Coughlan, T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S241 - S242
  • [36] VALIDATION OF THE LITHUANIAN VERSION OF SARCOPENIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE (SARQOL®)
    Alekna, V.
    Kilaite, J.
    Mastaviciute, A.
    Tamulaitiene, M.
    Beaudart, C.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S720 - S721
  • [37] Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL®)
    Prabal Kumar
    Shashikiran Umakanth
    N Girish
    BMC Musculoskeletal Disorders, 24
  • [38] PERSIAN TRANSLATION AND VALIDATION OF THE SARQOL®, A QUALITY OF LIFE QUESTIONNAIRE SPECIFIC TO SARCOPENIA
    Maghbooli, Z.
    Shirvani, A.
    Geerinck, A.
    Aghababaei, Y.
    Ramezani, M.
    Jalalinia, S. H.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S238 - S238
  • [39] SARCOPENIA AND QUALITY OF LIFE QUESTIONNAIRE (SARQOL®): GREEK CROSS CULTURAL ADAPTATION
    Tsekoura, M.
    Billis, E.
    Gliatis, J.
    Tsepis, E.
    Matzaroglou, C.
    Sakkas, G. K.
    Beaudart, C.
    Bruyere, O.
    Panagiotopoulos, E.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S213 - S214
  • [40] Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia
    Geerinck, Anton
    Scheppers, Annelies
    Beaudart, Charlotte
    Bruyere, Olivier
    Vandenbussche, Wim
    Bautmans, Rene
    Delye, Sam
    Bautmans, Ivan
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2018, 18 (04) : 463 - 472